
MMAD must remain below five microns to ensure effective drug deposition within the lower respiratory tract of pediatric patients.
High nebulization rates reduce treatment duration which is essential for improving compliance and reducing anxiety in restless young children.
Operational decibels should stay below fifty to prevent frightening patients and to allow for administration during sleep or rest.
Ergonomic designs and non-threatening aesthetics minimize clinical distress while ensuring a secure seal for maximum medication delivery to lungs.
